LAVA Therapeutics NV is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LVTX is expected to report earnings to rise 126.21% to -31 cents per share on May 14
Q1'25
Est.
$-0.32
Q4'24
Beat
by $0.16
Q3'24
Missed
by $0.13
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.29
The last earnings report on March 28 showed earnings per share of -14 cents, beating the estimate of -30 cents. With 6.44K shares outstanding, the current market capitalization sits at 33.41M.